Clinical Trials Browser

INDUSTRY × Recurrence × Fenretinide × Clear all

NCT06922539 2025-12-15

ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer

Phase 1 Recruiting

Recurrence, Small Cell Lung Carcinoma